Glycosylation, dolichyl-P-Man:GDP-Man1GlcNAc2-PP-dolichyl alpha-1,3-mannosyltransferase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: A4IA00
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0043413 | macromolecule glycosylation | 3 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0070085 | glycosylation | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 4 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000030 | mannosyltransferase activity | 5 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004376 | glycolipid mannosyltransferase activity | 6 | 11 |
GO:0004378 | GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity | 7 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016757 | glycosyltransferase activity | 3 | 11 |
GO:0016758 | hexosyltransferase activity | 4 | 11 |
GO:0102704 | GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity | 5 | 11 |
GO:0000033 | alpha-1,3-mannosyltransferase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 131 | 135 | PF00656 | 0.473 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.218 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.317 |
CLV_PCSK_FUR_1 | 36 | 40 | PF00082 | 0.330 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.266 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.289 |
CLV_PCSK_PC1ET2_1 | 107 | 109 | PF00082 | 0.266 |
CLV_PCSK_PC1ET2_1 | 38 | 40 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.283 |
CLV_PCSK_SKI1_1 | 249 | 253 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 306 | 310 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 393 | 397 | PF00082 | 0.263 |
CLV_PCSK_SKI1_1 | 403 | 407 | PF00082 | 0.180 |
CLV_PCSK_SKI1_1 | 522 | 526 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.260 |
CLV_Separin_Metazoa | 78 | 82 | PF03568 | 0.530 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.304 |
DEG_SCF_FBW7_2 | 413 | 420 | PF00400 | 0.408 |
DOC_CKS1_1 | 414 | 419 | PF01111 | 0.444 |
DOC_MAPK_gen_1 | 107 | 113 | PF00069 | 0.561 |
DOC_MAPK_gen_1 | 26 | 34 | PF00069 | 0.448 |
DOC_MAPK_gen_1 | 323 | 332 | PF00069 | 0.414 |
DOC_MAPK_gen_1 | 352 | 359 | PF00069 | 0.503 |
DOC_MAPK_JIP1_4 | 353 | 359 | PF00069 | 0.452 |
DOC_MAPK_MEF2A_6 | 326 | 334 | PF00069 | 0.408 |
DOC_MAPK_MEF2A_6 | 352 | 359 | PF00069 | 0.503 |
DOC_MAPK_MEF2A_6 | 77 | 84 | PF00069 | 0.444 |
DOC_MAPK_NFAT4_5 | 327 | 335 | PF00069 | 0.408 |
DOC_MAPK_RevD_3 | 23 | 38 | PF00069 | 0.319 |
DOC_PIKK_1 | 369 | 377 | PF02985 | 0.497 |
DOC_PP1_RVXF_1 | 79 | 85 | PF00149 | 0.481 |
DOC_PP2B_LxvP_1 | 385 | 388 | PF13499 | 0.503 |
DOC_PP4_FxxP_1 | 283 | 286 | PF00568 | 0.441 |
DOC_PP4_FxxP_1 | 84 | 87 | PF00568 | 0.453 |
DOC_USP7_MATH_1 | 444 | 448 | PF00917 | 0.408 |
DOC_USP7_MATH_1 | 540 | 544 | PF00917 | 0.675 |
DOC_USP7_UBL2_3 | 542 | 546 | PF12436 | 0.691 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.320 |
DOC_WW_Pin1_4 | 413 | 418 | PF00397 | 0.444 |
DOC_WW_Pin1_4 | 462 | 467 | PF00397 | 0.467 |
LIG_14-3-3_CanoR_1 | 220 | 229 | PF00244 | 0.634 |
LIG_14-3-3_CanoR_1 | 26 | 34 | PF00244 | 0.535 |
LIG_14-3-3_CanoR_1 | 386 | 395 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 515 | 524 | PF00244 | 0.540 |
LIG_BRCT_BRCA1_1 | 125 | 129 | PF00533 | 0.585 |
LIG_BRCT_BRCA1_1 | 246 | 250 | PF00533 | 0.545 |
LIG_CaM_IQ_9 | 504 | 519 | PF13499 | 0.493 |
LIG_CtBP_PxDLS_1 | 528 | 533 | PF00389 | 0.482 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.473 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.401 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.508 |
LIG_FHA_1 | 380 | 386 | PF00498 | 0.490 |
LIG_FHA_1 | 509 | 515 | PF00498 | 0.500 |
LIG_FHA_2 | 269 | 275 | PF00498 | 0.546 |
LIG_LIR_Apic_2 | 170 | 175 | PF02991 | 0.294 |
LIG_LIR_Apic_2 | 280 | 286 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 317 | 324 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 335 | 341 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 42 | 51 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 267 | 272 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 281 | 287 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 317 | 321 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 335 | 340 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 42 | 47 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 420 | 425 | PF02991 | 0.409 |
LIG_LYPXL_S_1 | 283 | 287 | PF13949 | 0.242 |
LIG_LYPXL_yS_3 | 284 | 287 | PF13949 | 0.445 |
LIG_Pex14_1 | 232 | 236 | PF04695 | 0.623 |
LIG_Pex14_2 | 168 | 172 | PF04695 | 0.320 |
LIG_Pex14_2 | 203 | 207 | PF04695 | 0.432 |
LIG_Pex14_2 | 8 | 12 | PF04695 | 0.304 |
LIG_PTB_Apo_2 | 254 | 261 | PF02174 | 0.441 |
LIG_REV1ctd_RIR_1 | 192 | 199 | PF16727 | 0.214 |
LIG_SH2_CRK | 432 | 436 | PF00017 | 0.488 |
LIG_SH2_CRK | 48 | 52 | PF00017 | 0.494 |
LIG_SH2_STAP1 | 373 | 377 | PF00017 | 0.430 |
LIG_SH2_STAP1 | 44 | 48 | PF00017 | 0.443 |
LIG_SH2_STAP1 | 484 | 488 | PF00017 | 0.503 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.548 |
LIG_SH2_STAT5 | 394 | 397 | PF00017 | 0.507 |
LIG_SH2_STAT5 | 415 | 418 | PF00017 | 0.444 |
LIG_SH3_3 | 411 | 417 | PF00018 | 0.457 |
LIG_SUMO_SIM_anti_2 | 115 | 120 | PF11976 | 0.493 |
LIG_SUMO_SIM_anti_2 | 2 | 7 | PF11976 | 0.301 |
LIG_SUMO_SIM_par_1 | 115 | 120 | PF11976 | 0.482 |
LIG_SUMO_SIM_par_1 | 435 | 441 | PF11976 | 0.523 |
LIG_TRAF2_1 | 128 | 131 | PF00917 | 0.524 |
LIG_TRAF2_1 | 55 | 58 | PF00917 | 0.669 |
LIG_TRAF2_2 | 208 | 213 | PF00917 | 0.450 |
LIG_TYR_ITIM | 282 | 287 | PF00017 | 0.441 |
MOD_CDK_SPxK_1 | 413 | 419 | PF00069 | 0.452 |
MOD_CK1_1 | 224 | 230 | PF00069 | 0.560 |
MOD_CK1_1 | 258 | 264 | PF00069 | 0.479 |
MOD_CK1_1 | 447 | 453 | PF00069 | 0.404 |
MOD_CK2_1 | 339 | 345 | PF00069 | 0.526 |
MOD_CK2_1 | 396 | 402 | PF00069 | 0.503 |
MOD_CK2_1 | 461 | 467 | PF00069 | 0.503 |
MOD_Cter_Amidation | 350 | 353 | PF01082 | 0.220 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.322 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.366 |
MOD_GlcNHglycan | 301 | 304 | PF01048 | 0.375 |
MOD_GlcNHglycan | 312 | 315 | PF01048 | 0.346 |
MOD_GlcNHglycan | 69 | 73 | PF01048 | 0.414 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.501 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.431 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.469 |
MOD_N-GLC_1 | 396 | 401 | PF02516 | 0.264 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.296 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.349 |
MOD_NEK2_1 | 299 | 304 | PF00069 | 0.580 |
MOD_NEK2_1 | 339 | 344 | PF00069 | 0.428 |
MOD_NEK2_1 | 380 | 385 | PF00069 | 0.417 |
MOD_NEK2_1 | 430 | 435 | PF00069 | 0.452 |
MOD_NEK2_2 | 218 | 223 | PF00069 | 0.569 |
MOD_PIKK_1 | 297 | 303 | PF00454 | 0.446 |
MOD_PIKK_1 | 387 | 393 | PF00454 | 0.503 |
MOD_PIKK_1 | 541 | 547 | PF00454 | 0.643 |
MOD_PK_1 | 107 | 113 | PF00069 | 0.507 |
MOD_PKA_1 | 107 | 113 | PF00069 | 0.474 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.521 |
MOD_PKA_2 | 141 | 147 | PF00069 | 0.548 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.544 |
MOD_Plk_1 | 218 | 224 | PF00069 | 0.489 |
MOD_Plk_1 | 243 | 249 | PF00069 | 0.598 |
MOD_Plk_2-3 | 498 | 504 | PF00069 | 0.511 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.496 |
MOD_Plk_4 | 314 | 320 | PF00069 | 0.452 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.320 |
MOD_ProDKin_1 | 413 | 419 | PF00069 | 0.444 |
MOD_ProDKin_1 | 462 | 468 | PF00069 | 0.467 |
MOD_SUMO_for_1 | 532 | 535 | PF00179 | 0.664 |
MOD_SUMO_rev_2 | 302 | 311 | PF00179 | 0.511 |
MOD_SUMO_rev_2 | 342 | 349 | PF00179 | 0.509 |
MOD_SUMO_rev_2 | 399 | 405 | PF00179 | 0.506 |
MOD_SUMO_rev_2 | 518 | 525 | PF00179 | 0.539 |
TRG_DiLeu_BaEn_1 | 335 | 340 | PF01217 | 0.503 |
TRG_DiLeu_BaEn_1 | 402 | 407 | PF01217 | 0.464 |
TRG_DiLeu_BaEn_1 | 409 | 414 | PF01217 | 0.464 |
TRG_DiLeu_BaLyEn_6 | 93 | 98 | PF01217 | 0.471 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.305 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.436 |
TRG_ENDOCYTIC_2 | 236 | 239 | PF00928 | 0.462 |
TRG_ENDOCYTIC_2 | 284 | 287 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.521 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.512 |
TRG_ER_diArg_1 | 153 | 156 | PF00400 | 0.429 |
TRG_ER_diArg_1 | 25 | 28 | PF00400 | 0.523 |
TRG_ER_diArg_1 | 36 | 39 | PF00400 | 0.567 |
TRG_ER_diArg_1 | 493 | 496 | PF00400 | 0.502 |
TRG_ER_diArg_1 | 514 | 517 | PF00400 | 0.533 |
TRG_ER_diLys_1 | 546 | 550 | PF00400 | 0.670 |
TRG_NLS_MonoExtC_3 | 36 | 42 | PF00514 | 0.464 |
TRG_NLS_MonoExtN_4 | 36 | 41 | PF00514 | 0.461 |
TRG_Pf-PMV_PEXEL_1 | 306 | 310 | PF00026 | 0.367 |
TRG_Pf-PMV_PEXEL_1 | 523 | 527 | PF00026 | 0.318 |
TRG_Pf-PMV_PEXEL_1 | 96 | 100 | PF00026 | 0.259 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8W1 | Leptomonas seymouri | 64% | 97% |
A0A0S4INF7 | Bodo saltans | 46% | 100% |
A0A1X0P9N2 | Trypanosomatidae | 47% | 100% |
A0A3Q8IEF0 | Leishmania donovani | 99% | 100% |
A0A3R7N194 | Trypanosoma rangeli | 44% | 100% |
A4HAV3 | Leishmania braziliensis | 83% | 100% |
C9ZML3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9B528 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
O94738 | Rhizomucor pusillus | 38% | 100% |
P43636 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 34% | 100% |
Q08B22 | Xenopus laevis | 27% | 100% |
Q3TZM9 | Mus musculus | 27% | 100% |
Q4Q2V8 | Leishmania major | 93% | 100% |
Q59LF2 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 36% | 100% |
Q6BVA4 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 34% | 100% |
Q6C3V7 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 37% | 100% |
Q6CWQ0 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 39% | 100% |
Q6FJJ9 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 35% | 100% |
Q6P312 | Xenopus tropicalis | 26% | 100% |
Q755C1 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 36% | 100% |
Q7KWM5 | Dictyostelium discoideum | 34% | 100% |
Q8X0H8 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 37% | 100% |
Q96WW6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 100% |
Q9DBE8 | Mus musculus | 37% | 100% |
Q9H553 | Homo sapiens | 37% | 100% |